- Disease: Acute COVID-19
- Study type: Observational Cohort Study, Treatment
- Study type descriptors: Retrospective, Single centre
- Objective: To evaluate the impact of SARS-CoV-2 vaccination on virological clearance, COVID-19 related hospitalization, ICU admission, and 30-day mortality in SARS-CoV-2 infected patients receiving monoclonal antibodies due to their risk for COVID-19 progression
- Number of participants enrolled: 726
- Study enrolling from to
- Study includes follow-up for 1 month
Study Data
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Fragile population
- Hospital
- Emergency department
- Infectious diseases unit
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Monoclonal antibodies
- Sotrovimab
- Tixagevimab/Cilgavimab
- Casirivimab/Imdevimab
- Bamlanivimab/ Etesevimab
External Links
Other information
The information was provided with the aid of the study investigators
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to